Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2022-10-07 00:00:00 ET · period of report 2022-10-06 · accession 0001654954-22-013528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-07 | 2022-10-06 | DRMA | HALE DAVID F | Dir | A - Grant | $0.00 | +30.2K | 75.7K | +66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-06 | A | A | 30,155 | $0.00 | 75,720 | D | — | — | (F1) On October 6, 2022, the Reporting Person was granted 30,155 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan. |